In honor of Lupus Awareness Month, we will look at new studies published in the field of lupus research.

Patients with autoimmune diseases are familiar with the impact on our neurological system and brain, leading to symptoms like brain fog, neuropathy, and tremors.

If it seems like we hear more about people being diagnosed with autoimmune diseases these days, it's because they are.

One of the most common symptoms reported by patients with any autoimmune disease is fatigue, which is reported by many as the "most debilitating symptom."

While the presence of T-cell activating proteins doesn't necessarily mean Parkinson's is autoimmune, a recent meta study has revealed an increased risk for Parkinson's among certain autoimmune diseases.

Those with autoimmune diseases may be especially vulnerable against COVID-19, with some more likely to develop long Covid than the average population.

One of the Autoimmune Registry's goals has always been to support research by connecting patients to clinical trials. New treatments and therapies require . . .

With more than 100 confirmed and suspected autoimmune diseases that collectively affect over 24 million people (just in the US), let’s make sure our diseases do not remain invisible.

In 2020, as COVID-19 spread around the world, more and more patients realized their symptoms didn’t go away. Brain fog, fatigue, and shortness of breath . . .

Another study has just been published that has identified a receptor in our gut lining that can "reprogram the gut microbiome to promote harmful, chronic inflammation."